Drug Shortage Report for MIDAZOLAM INJECTION

Last updated on 2019-01-16 History
Report ID 66342
Drug Identification Number 02240285
Brand name MIDAZOLAM INJECTION
Common or Proper name MIDAZOLAM
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) MIDAZOLAM
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 2ML X 10 VIALS
ATC code N05CD
ATC description HYPNOTICS AND SEDATIVES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-10-15
Estimated end date 2018-12-17
Actual end date 2019-01-07
Shortage status Resolved
Updated date 2019-01-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2019-01-16 French Compare
v3 2019-01-16 English Compare
v2 2018-11-06 French Compare
v1 2018-11-06 English Compare

Showing 1 to 4 of 4